GeneDx Holdings Corp. (NAS: WGS) Stock Analysis & Fundamentals | ScreenerHero

Create free account

WGSGeneDx Holdings Corp.

NAS · US · Healthcare · Diagnostics & Research · genedx.com

61.69USD-6.73%Mkt Cap: 1.83B $P/E: —1d ago

GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and inf…

Industry Peers

Diagnostics & Research

Thermo Fisher Scientific Inc.

$201.86BUSDP/E 29.8

Danaher Corporation

$145.10BUSDP/E 39.7

$45.85BUSDP/E 44.2

IDEXX Laboratories, Inc.

$45.44BUSDP/E 42.4

Agilent Technologies, Inc.

$38.44BUSDP/E 27.3

Waters Corporation

$37.13BUSDP/E 48.1

IQVIA Holdings Inc.

$35.13BUSDP/E 26.2

$28.78BUSDP/E 34.6

Mettler-Toledo International Inc.

$26.98BUSDP/E 31.4

Quest Diagnostics Incorporated

$23.18BUSDP/E 23.1

Labcorp Holdings Inc.

$23.12BUSDP/E 25.0

Guardant Health, Inc.

Medpace Holdings, Inc.

$15.36BUSDP/E 33.9

Eurofins Scientific SE

$13.06BUSDP/E 27.3

$12.46BUSDP/E 53.7

Charles River Laboratories International, Inc.

bioMérieux S.A.

$9.26BUSDP/E 21.6

BillionToOne, Inc.

$5.90BUSDP/E 237.4

Twist Bioscience Corporation

Sotera Health Company

$5.21BUSDP/E 44.6

$4.73BUSDP/E 54.8

DiaSorin S.p.A.

$3.75BUSDP/E 26.5

Adaptive Biotechnologies Corporation

NeoGenomics, Inc.

Vimian Group AB (publ)

$1.64BUSDP/E 41.7

Personalis, Inc.

Diagnostyka S.A.

$1.48BUSDP/E 22.4

Clínica Baviera, S.A.

$1.02BUSDP/E 21.4

OPKO Health, Inc.

Castle Biosciences, Inc.

$616.40MUSDP/E 40.2

Myriad Genetics, Inc.

Fulgent Genetics, Inc.

$293.12MUSDP/E 2.9

Spectral Medical Inc.

Insight Molecular Diagnostics Inc.

Scope Fluidics S.A.

Eurofins-Cerep SA

$89.37MUSDP/E 17.2

Pangaea Oncology, S.A.

Abingdon Health Plc

Immunovia AB (publ)

Proteome Sciences plc

ENDRA Life Sciences Inc.

Oxford BioDynamics Plc

Avricore Health Inc.

bioAffinity Technologies, Inc.

Leveljump Healthcare Corp.

Prostatype Genomics AB (publ)

Telo Genomics Corp.

ProPhase Labs, Inc.

Many Bright Ideas Technologies Inc.

$314.2KUSDP/E Infinity

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap1.83B $

Enterprise Value1.83B $

Revenue (TTM)442.68M $

Gross Profit298.17M $

Net Income (TTM)-21.02M $

Revenue/Share15.30 USD

Last Price61.69 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees1.3K

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)55.89

PEG—

EV/EBITDA-232.99

EV/Revenue4.13

P/S4.14

P/B7.20

EPS (TTM)-2.66

EPS (Forward)1.10

52W Range

32.2121% of range170.87

52W High170.87 USD

52W Low32.21 USD

Profitability

Gross Margin69.74%

Oper. Margin-25.61%

EBITDA Margin-1.77%

Profit Margin-4.92%

ROE-6.82%

ROA-4.01%

Growth

Revenue Growth17.40%

Earnings Growth—

Cash Flow & Leverage

Operating CF33.28M $

CapEx (TTM)19.02M $

FCF Margin0.82%

FCF Yield0.20%

Net Debt-2.49M $

Net Debt/EBITDA0.32

Balance Sheet

Debt/Equity0.37

Current Ratio3.09

Quick Ratio2.83

Book Value/Sh8.566 USD

Cash/Share5.749 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:33

Split DateMay 4, 2023

Analyst Consensus

Rating1.1 (Strong Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)81.78 USD

Upside (mean)+32.6%

Target Range63.00 USD – 100.00 USD

$63.00+32.6% to mean$100.00

# Analysts9

Ownership

Shares Out.29.69M

Float18.94M

Insiders12.31%

Institutions115.43%

Short Interest

Short Ratio5.2d

Short % Float38.46%

Short % Out.20.01%

Shares Short5.94M

Short (prev mo.)4.57M

Technical

SMA 5054.95 (+12.3%)

SMA 20094.38 (-34.6%)

Beta1.91

S&P 52W Chg20.25%

Avg Vol (30d)970.36K

Avg Vol (10d)698.92K

Technical Indicators

RSI (14)48.8

MACD2.0881

MACD Signal3.0162

MACD Hist.-0.9281

BB Upper74.23 USD

BB Middle64.60 USD

BB Lower54.97 USD

BB Width29.83%

ATR (14)4.632 USD

Vol Ratio (20d)1.05x